Product

JZP341

1 clinical trial

2 indications

Indication

Advanced Solid Tumor

Indication

Metastatic Solid Tumor

Clinical trial

Phase 1, Open-Label, Dose-Finding, and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of JZP341 in Adult Participants With Advanced or Metastatic Solid Tumors

Status: Active (not recruiting), Estimated PCD: 2024-11-29